APO Research
Talk to an analyst

APO RESEARCH · REPORT

Human Combination Vaccines

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Human Combination Vaccines Market Analysis and Forecast 2026-2032

22 December 2025197 pages

Choose your research edition.

Industry ResearchHuman Combination Vaccines Industry Research Report 2026116 pages · $2,950 USDIndustry Growth & TrendsGlobal Human Combination Vaccines Industry Growth and Trends Forecast to 203293 pages · $3,450 USDMarket StructureGlobal Human Combination Vaccines Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032186 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Human Combination Vaccines Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Human Combination Vaccines Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

The global Human Combination Vaccines market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Human Combination Vaccines is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Human Combination Vaccines is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Human Combination Vaccines is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Human Combination Vaccines is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Human Combination Vaccines include Takeda Pharmaceuticals, Sanofi, Merck, GlaxoSmithKline, Serum Institute of India and Daiichi Sankyo, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Human Combination Vaccines, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Human Combination Vaccines, also provides the sales of main regions and countries. Of the upcoming market potential for Human Combination Vaccines, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Human Combination Vaccines sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Human Combination Vaccines market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Human Combination Vaccines sales, projected growth trends, production technology, application and end-user industry.

Human Combination Vaccines Segment by Company

Takeda Pharmaceuticals

Sanofi

Merck

GlaxoSmithKline

Serum Institute of India

Daiichi Sankyo

Human Combination Vaccines Segment by Type

Human Combination Inactivated Vaccines

Human Combination Live Attenuated Vaccines

Human Combination Vaccines Segment by Application

Hospitals

Clinics

Others

Human Combination Vaccines Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Human Combination Vaccines market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Human Combination Vaccines and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Human Combination Vaccines.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Human Combination Vaccines in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Human Combination Vaccines manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Human Combination Vaccines sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Human Combination Vaccines Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Human Combination Inactivated Vaccines Major Manufacturers Table 3. Human Combination Live Attenuated Vaccines Major Manufacturers Table 4. Global Human Combination Vaccines Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Hospitals Major Manufacturers Table 6. Clinics Major Manufacturers Table 7. Others Major Manufacturers Table 8. Human Combination Vaccines Industry Trends Table 9. Human Combination Vaccines Industry Drivers Table 10. Human Combination Vaccines Industry Opportunities and Challenges Table 11. Human Combination Vaccines Industry Restraints Table 12. Global Human Combination Vaccines Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 13. Global Human Combination Vaccines Revenue by Region (2021-2026) & (US$ Million) Table 14. Global Human Combination Vaccines Revenue by Region (2027-2032) & (US$ Million) Table 15. Global Human Combination Vaccines Revenue Market Share by Region (2021-2026) Table 16. Global Human Combination Vaccines Revenue Market Share by Region (2027-2032) Table 17. Global Human Combination Vaccines Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (k units) Table 18. Global Human Combination Vaccines Sales by Region (2021-2026) & (k units) Table 19. Global Human Combination Vaccines Sales by Region (2027-2032) & (k units) Table 20. Global Human Combination Vaccines Sales Market Share by Region (2021-2026) Table 21. Global Human Combination Vaccines Sales Market Share by Region (2027-2032) Table 22. Global Human Combination Vaccines Revenue by Manufacturers (US$ Million) & (2021-2026) Table 23. Global Human Combination Vaccines Revenue Market Share by Manufacturers (2021-2026) Table 24. Global Human Combination Vaccines Sales by Manufacturers (US$ Million) & (2021-2026) Table 25. Global Human Combination Vaccines Sales Market Share by Manufacturers (2021-2026) Table 26. Global Human Combination Vaccines Sales Price (US$/unit) of Manufacturers (2021-2026) Table 27. Global Human Combination Vaccines Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 28. Global Human Combination Vaccines Key Manufacturers Manufacturing Sites & Headquarters Table 29. Global Human Combination Vaccines Manufacturers, Product Type & Application Table 30. Global Human Combination Vaccines Manufacturers' Establishment Date Table 31. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 32. Global Human Combination Vaccines by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 33. Global Human Combination Vaccines Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Human Combination Vaccines Revenue by Type (2021-2026) & (US$ Million) Table 35. Global Human Combination Vaccines Revenue by Type (2027-2032) & (US$ Million) Table 36. Global Human Combination Vaccines Revenue Market Share by Type (2021-2026) Table 37. Global Human Combination Vaccines Revenue Market Share by Type (2027-2032) Table 38. Global Human Combination Vaccines Sales by Type 2021 VS 2025 VS 2032 (k units) Table 39. Global Human Combination Vaccines Sales by Type (2021-2026) & (k units) Table 40. Global Human Combination Vaccines Sales by Type (2027-2032) & (k units) Table 41. Global Human Combination Vaccines Sales Market Share by Type (2021-2026) Table 42. Global Human Combination Vaccines Sales Market Share by Type (2027-2032) Table 43. Global Human Combination Vaccines Price by Type (2021-2026) & (US$/unit) Table 44. Global Human Combination Vaccines Price by Type (2027-2032) & (US$/unit) Table 45. Global Human Combination Vaccines Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 46. Global Human Combination Vaccines Revenue by Application (2021-2026) & (US$ Million) Table 47. Global Human Combination Vaccines Revenue by Application (2027-2032) & (US$ Million) Table 48. Global Human Combination Vaccines Revenue Market Share by Application (2021-2026) Table 49. Global Human Combination Vaccines Revenue Market Share by Application (2027-2032) Table 50. Global Human Combination Vaccines Sales by Application 2021 VS 2025 VS 2032 (k units) Table 51. Global Human Combination Vaccines Sales by Application (2021-2026) & (k units) Table 52. Global Human Combination Vaccines Sales by Application (2027-2032) & (k units) Table 53. Global Human Combination Vaccines Sales Market Share by Application (2021-2026) Table 54. Global Human Combination Vaccines Sales Market Share by Application (2027-2032) Table 55. Global Human Combination Vaccines Price by Application (2021-2026) & (US$/unit) Table 56. Global Human Combination Vaccines Price by Application (2027-2032) & (US$/unit) Table 57. Takeda Pharmaceuticals Company Information Table 58. Takeda Pharmaceuticals Business Overview Table 59. Takeda Pharmaceuticals Human Combination Vaccines Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 60. Takeda Pharmaceuticals Human Combination Vaccines Product Portfolio Table 61. Takeda Pharmaceuticals Recent Development Table 62. Sanofi Company Information Table 63. Sanofi Business Overview Table 64. Sanofi Human Combination Vaccines Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 65. Sanofi Human Combination Vaccines Product Portfolio Table 66. Sanofi Recent Development Table 67. Merck Company Information Table 68. Merck Business Overview Table 69. Merck Human Combination Vaccines Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 70. Merck Human Combination Vaccines Product Portfolio Table 71. Merck Recent Development Table 72. GlaxoSmithKline Company Information Table 73. GlaxoSmithKline Business Overview Table 74. GlaxoSmithKline Human Combination Vaccines Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 75. GlaxoSmithKline Human Combination Vaccines Product Portfolio Table 76. GlaxoSmithKline Recent Development Table 77. Serum Institute of India Company Information Table 78. Serum Institute of India Business Overview Table 79. Serum Institute of India Human Combination Vaccines Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 80. Serum Institute of India Human Combination Vaccines Product Portfolio Table 81. Serum Institute of India Recent Development Table 82. Daiichi Sankyo Company Information Table 83. Daiichi Sankyo Business Overview Table 84. Daiichi Sankyo Human Combination Vaccines Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 85. Daiichi Sankyo Human Combination Vaccines Product Portfolio Table 86. Daiichi Sankyo Recent Development Table 87. North America Human Combination Vaccines Revenue by Type (2021-2026) & (US$ Million) Table 88. North America Human Combination Vaccines Revenue by Type (2027-2032) & (US$ Million) Table 89. North America Human Combination Vaccines Sales by Type (2021-2026) & (k units) Table 90. North America Human Combination Vaccines Sales by Type (2027-2032) & (k units) Table 91. North America Human Combination Vaccines Sales Price by Type (2021-2026) & (US$/unit) Table 92. North America Human Combination Vaccines Sales Price by Type (2027-2032) & (US$/unit) Table 93. North America Human Combination Vaccines Revenue by Application (2021-2026) & (US$ Million) Table 94. North America Human Combination Vaccines Revenue by Application (2027-2032) & (US$ Million) Table 95. North America Human Combination Vaccines Sales by Application (2021-2026) & (k units) Table 96. North America Human Combination Vaccines Sales by Application (2027-2032) & (k units) Table 97. North America Human Combination Vaccines Sales Price by Application (2021-2026) & (US$/unit) Table 98. North America Human Combination Vaccines Sales Price by Application (2027-2032) & (US$/unit) Table 99. North America Human Combination Vaccines Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 100. North America Human Combination Vaccines Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 101. North America Human Combination Vaccines Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 102. North America Human Combination Vaccines Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 103. North America Human Combination Vaccines Sales by Country (2021-2026) & (k units) Table 104. North America Human Combination Vaccines Sales by Country (2027-2032) & (k units) Table 105. North America Human Combination Vaccines Sales Price by Country (2021-2026) & (US$/unit) Table 106. North America Human Combination Vaccines Sales Price by Country (2027-2032) & (US$/unit) Table 107. United States Human Combination Vaccines Revenue (2021-2032) & (US$ Million) Table 108. Canada Human Combination Vaccines Revenue (2021-2032) & (US$ Million) Table 109. Mexico Human Combination Vaccines Revenue (2021-2032) & (US$ Million) Table 110. Europe Human Combination Vaccines Revenue by Type (2021-2026) & (US$ Million) Table 111. Europe Human Combination Vaccines Revenue by Type (2027-2032) & (US$ Million) Table 112. Europe Human Combination Vaccines Sales by Type (2021-2026) & (k units) Table 113. Europe Human Combination Vaccines Sales by Type (2027-2032) & (k units) Table 114. Europe Human Combination Vaccines Sales Price by Type (2021-2026) & (US$/unit) Table 115. Europe Human Combination Vaccines Sales Price by Type (2027-2032) & (US$/unit) Table 116. Europe Human Combination Vaccines Revenue by Application (2021-2026) & (US$ Million) Table 117. Europe Human Combination Vaccines Revenue by Application (2027-2032) & (US$ Million) Table 118. Europe Human Combination Vaccines Sales by Application (2021-2026) & (k units) Table 119. Europe Human Combination Vaccines Sales by Application (2027-2032) & (k units) Table 120. Europe Human Combination Vaccines Sales Price by Application (2021-2026) & (US$/unit) Table 121. Europe Human Combination Vaccines Sales Price by Application (2027-2032) & (US$/unit) Table 122. Europe Human Combination Vaccines Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 123. Europe Human Combination Vaccines Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 124. Europe Human Combination Vaccines Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 125. Europe Human Combination Vaccines Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 126. Europe Human Combination Vaccines Sales by Country (2021-2026) & (k units) Table 127. Europe Human Combination Vaccines Sales by Country (2027-2032) & (k units) Table 128. Europe Human Combination Vaccines Sales Price by Country (2021-2026) & (US$/unit) Table 129. Europe Human Combination Vaccines Sales Price by Country (2027-2032) & (US$/unit) Table 130. Germany Human Combination Vaccines Revenue (2021-2032) & (US$ Million) Table 131. France Human Combination Vaccines Revenue (2021-2032) & (US$ Million) Table 132. U.K. Human Combination Vaccines Revenue (2021-2032) & (US$ Million) Table 133. Italy Human Combination Vaccines Revenue (2021-2032) & (US$ Million) Table 134. Russia Human Combination Vaccines Revenue (2021-2032) & (US$ Million) Table 135. Spain Human Combination Vaccines Revenue (2021-2032) & (US$ Million) Table 136. Netherlands Human Combination Vaccines Revenue (2021-2032) & (US$ Million) Table 137. Switzerland Human Combination Vaccines Revenue (2021-2032) & (US$ Million) Table 138. Sweden Human Combination Vaccines Revenue (2021-2032) & (US$ Million) Table 139. Poland Human Combination Vaccines Revenue (2021-2032) & (US$ Million) Table 140. China Human Combination Vaccines Revenue by Type (2021-2026) & (US$ Million) Table 141. China Human Combination Vaccines Revenue by Type (2027-2032) & (US$ Million) Table 142. China Human Combination Vaccines Sales by Type (2021-2026) & (k units) Table 143. China Human Combination Vaccines Sales by Type (2027-2032) & (k units) Table 144. China Human Combination Vaccines Sales Price by Type (2021-2026) & (US$/unit) Table 145. China Human Combination Vaccines Sales Price by Type (2027-2032) & (US$/unit) Table 146. China Human Combination Vaccines Revenue by Application (2021-2026) & (US$ Million) Table 147. China Human Combination Vaccines Revenue by Application (2027-2032) & (US$ Million) Table 148. China Human Combination Vaccines Sales by Application (2021-2026) & (k units) Table 149. China Human Combination Vaccines Sales by Application (2027-2032) & (k units) Table 150. China Human Combination Vaccines Sales Price by Application (2021-2026) & (US$/unit) Table 151. China Human Combination Vaccines Sales Price by Application (2027-2032) & (US$/unit) Table 152. Asia Human Combination Vaccines Revenue by Type (2021-2026) & (US$ Million) Table 153. Asia Human Combination Vaccines Revenue by Type (2027-2032) & (US$ Million) Table 154. Asia Human Combination Vaccines Sales by Type (2021-2026) & (k units) Table 155. Asia Human Combination Vaccines Sales by Type (2027-2032) & (k units) Table 156. Asia Human Combination Vaccines Sales Price by Type (2021-2026) & (US$/unit) Table 157. Asia Human Combination Vaccines Sales Price by Type (2027-2032) & (US$/unit) Table 158. Asia Human Combination Vaccines Revenue by Application (2021-2026) & (US$ Million) Table 159. Asia Human Combination Vaccines Revenue by Application (2027-2032) & (US$ Million) Table 160. Asia Human Combination Vaccines Sales by Application (2021-2026) & (k units) Table 161. Asia Human Combination Vaccines Sales by Application (2027-2032) & (k units) Table 162. Asia Human Combination Vaccines Sales Price by Application (2021-2026) & (US$/unit) Table 163. Asia Human Combination Vaccines Sales Price by Application (2027-2032) & (US$/unit) Table 164. Asia Human Combination Vaccines Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 165. Asia Human Combination Vaccines Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 166. Asia Human Combination Vaccines Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 167. Asia Human Combination Vaccines Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 168. Asia Human Combination Vaccines Sales by Country (2021-2026) & (k units) Table 169. Asia Human Combination Vaccines Sales by Country (2027-2032) & (k units) Table 170. Asia Human Combination Vaccines Sales Price by Country (2021-2026) & (US$/unit) Table 171. Asia Human Combination Vaccines Sales Price by Country (2027-2032) & (US$/unit) Table 172. Japan Human Combination Vaccines Revenue (2021-2032) & (US$ Million) Table 173. South Korea Human Combination Vaccines Revenue (2021-2032) & (US$ Million) Table 174. India Human Combination Vaccines Revenue (2021-2032) & (US$ Million) Table 175. Australia Human Combination Vaccines Revenue (2021-2032) & (US$ Million) Table 176. Taiwan Human Combination Vaccines Revenue (2021-2032) & (US$ Million) Table 177. Southeast Asia Human Combination Vaccines Revenue (2021-2032) & (US$ Million) Table 178. SAMEA Human Combination Vaccines Revenue by Type (2021-2026) & (US$ Million) Table 179. SAMEA Human Combination Vaccines Revenue by Type (2027-2032) & (US$ Million) Table 180. SAMEA Human Combination Vaccines Sales by Type (2021-2026) & (k units) Table 181. SAMEA Human Combination Vaccines Sales by Type (2027-2032) & (k units) Table 182. SAMEA Human Combination Vaccines Sales Price by Type (2021-2026) & (US$/unit) Table 183. SAMEA Human Combination Vaccines Sales Price by Type (2027-2032) & (US$/unit) Table 184. SAMEA Human Combination Vaccines Revenue by Application (2021-2026) & (US$ Million) Table 185. SAMEA Human Combination Vaccines Revenue by Application (2027-2032) & (US$ Million) Table 186. SAMEA Human Combination Vaccines Sales by Application (2021-2026) & (k units) Table 187. SAMEA Human Combination Vaccines Sales by Application (2027-2032) & (k units) Table 188. SAMEA Human Combination Vaccines Sales Price by Application (2021-2026) & (US$/unit) Table 189. SAMEA Human Combination Vaccines Sales Price by Application (2027-2032) & (US$/unit) Table 190. SAMEA Human Combination Vaccines Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 191. SAMEA Human Combination Vaccines Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 192. SAMEA Human Combination Vaccines Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 193. SAMEA Human Combination Vaccines Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 194. SAMEA Human Combination Vaccines Sales by Country (2021-2026) & (k units) Table 195. SAMEA Human Combination Vaccines Sales by Country (2027-2032) & (k units) Table 196. SAMEA Human Combination Vaccines Sales Price by Country (2021-2026) & (US$/unit) Table 197. SAMEA Human Combination Vaccines Sales Price by Country (2027-2032) & (US$/unit) Table 198. Brazil Human Combination Vaccines Revenue (2021-2032) & (US$ Million) Table 199. Argentina Human Combination Vaccines Revenue (2021-2032) & (US$ Million) Table 200. Chile Human Combination Vaccines Revenue (2021-2032) & (US$ Million) Table 201. Colombia Human Combination Vaccines Revenue (2021-2032) & (US$ Million) Table 202. Peru Human Combination Vaccines Revenue (2021-2032) & (US$ Million) Table 203. Saudi Arabia Human Combination Vaccines Revenue (2021-2032) & (US$ Million) Table 204. Israel Human Combination Vaccines Revenue (2021-2032) & (US$ Million) Table 205. UAE Human Combination Vaccines Revenue (2021-2032) & (US$ Million) Table 206. Turkey Human Combination Vaccines Revenue (2021-2032) & (US$ Million) Table 207. Iran Human Combination Vaccines Revenue (2021-2032) & (US$ Million) Table 208. Egypt Human Combination Vaccines Revenue (2021-2032) & (US$ Million) Table 209. Key Raw Materials Table 210. Raw Materials Key Suppliers Table 211. Human Combination Vaccines Distributors List Table 212. Human Combination Vaccines Customers List Table 213. Research Programs/Design for This Report Table 214. Authors List of This Report Table 215. Secondary Sources Table 216. Primary Sources List of Figures Figure 1. Human Combination Vaccines Image Figure 2. Global Human Combination Vaccines Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Human Combination Vaccines Market Size Share 2021 VS 2025 VS 2032 Figure 4. Human Combination Inactivated Vaccines Image Figure 5. Human Combination Live Attenuated Vaccines Image Figure 6. Global Human Combination Vaccines Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Human Combination Vaccines Market Size Share 2021 VS 2025 VS 2032 Figure 8. Hospitals Image Figure 9. Clinics Image Figure 10. Others Image Figure 11. Global Human Combination Vaccines Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 12. Global Human Combination Vaccines Revenue (2021-2032) & (US$ Million) Figure 13. Global Human Combination Vaccines Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 14. Global Human Combination Vaccines Revenue Market Share by Region: 2025 Versus 2032 Figure 15. Global Human Combination Vaccines Revenue Market Share by Region (2021-2032) Figure 16. Global Human Combination Vaccines Sales (2021-2032) & (k units) Figure 17. Global Human Combination Vaccines Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 18. Global Human Combination Vaccines Sales Market Share by Region (2021-2032) Figure 19. US & Canada & Mexico Human Combination Vaccines Sales YoY (2021-2032) & (k units) Figure 20. Europe Human Combination Vaccines Sales YoY (2021-2032) & (k units) Figure 21. China Human Combination Vaccines Sales YoY (2021-2032) & (k units) Figure 22. Asia (Excluding China) Human Combination Vaccines Sales YoY (2021-2032) & (k units) Figure 23. South America, Middle East and Africa Human Combination Vaccines Sales YoY (2021-2032) & (k units) Figure 24. Global Human Combination Vaccines Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 25. Global Human Combination Vaccines Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 26. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Global Human Combination Vaccines Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 28. Global Human Combination Vaccines Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 29. Global Human Combination Vaccines Revenue Market Share by Type (2021-2032) Figure 30. Global Human Combination Vaccines Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 31. Global Human Combination Vaccines Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 32. Global Human Combination Vaccines Sales Market Share by Type (2021-2032) Figure 33. Global Human Combination Vaccines Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 34. Global Human Combination Vaccines Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 35. Global Human Combination Vaccines Revenue Market Share by Application (2021-2032) Figure 36. Global Human Combination Vaccines Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 37. Global Human Combination Vaccines Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 38. Global Human Combination Vaccines Sales Market Share by Application (2021-2032) Figure 39. North America Human Combination Vaccines Revenue Share by Type (2021-2032) Figure 40. North America Human Combination Vaccines Sales Share by Type (2021-2032) Figure 41. North America Human Combination Vaccines Revenue Share by Application (2021-2032) Figure 42. North America Human Combination Vaccines Sales Share by Application (2021-2032) Figure 43. North America Human Combination Vaccines Revenue Share by Country (2021-2032) Figure 44. North America Human Combination Vaccines Sales Share by Country (2021-2032) Figure 45. Europe Human Combination Vaccines Revenue Share by Type (2021-2032) Figure 46. Europe Human Combination Vaccines Sales Share by Type (2021-2032) Figure 47. Europe Human Combination Vaccines Revenue Share by Application (2021-2032) Figure 48. Europe Human Combination Vaccines Sales Share by Application (2021-2032) Figure 49. Europe Human Combination Vaccines Revenue Share by Country (2021-2032) Figure 50. Europe Human Combination Vaccines Sales Share by Country (2021-2032) Figure 51. China Human Combination Vaccines Revenue Share by Type (2021-2032) Figure 52. China Human Combination Vaccines Sales Share by Type (2021-2032) Figure 53. China Human Combination Vaccines Revenue Share by Application (2021-2032) Figure 54. China Human Combination Vaccines Sales Share by Application (2021-2032) Figure 55. Asia Human Combination Vaccines Revenue Share by Type (2021-2032) Figure 56. Asia Human Combination Vaccines Sales Share by Type (2021-2032) Figure 57. Asia Human Combination Vaccines Revenue Share by Application (2021-2032) Figure 58. Asia Human Combination Vaccines Sales Share by Application (2021-2032) Figure 59. Asia Human Combination Vaccines Revenue Share by Country (2021-2032) Figure 60. Asia Human Combination Vaccines Sales Share by Country (2021-2032) Figure 61. SAMEA Human Combination Vaccines Revenue Share by Type (2021-2032) Figure 62. SAMEA Human Combination Vaccines Sales Share by Type (2021-2032) Figure 63. SAMEA Human Combination Vaccines Revenue Share by Application (2021-2032) Figure 64. SAMEA Human Combination Vaccines Sales Share by Application (2021-2032) Figure 65. SAMEA Human Combination Vaccines Revenue Share by Country (2021-2032) Figure 66. SAMEA Human Combination Vaccines Sales Share by Country (2021-2032) Figure 67. Human Combination Vaccines Value Chain Figure 68. Manufacturing Cost Structure Figure 69. Human Combination Vaccines Production Mode & Process Figure 70. Direct Comparison with Distribution Share Figure 71. Distributors Profiles Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • Human Combination Inactivated Vaccines
  • Human Combination Live Attenuated Vaccines
Applications
  • Hospitals
  • Clinics
  • Others
Companies covered
  • Takeda Pharmaceuticals
  • Sanofi
  • Merck
  • GlaxoSmithKline
  • Serum Institute of India
  • Daiichi Sankyo

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Human Combination Vaccines Market by Type
  3. 1.2.1 Global Human Combination Vaccines Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Human Combination Inactivated Vaccines
  5. 1.2.3 Human Combination Live Attenuated Vaccines
  6. 1.3 Human Combination Vaccines Market by Application
  7. 1.3.1 Global Human Combination Vaccines Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Hospitals
  9. 1.3.3 Clinics
  10. 1.3.4 Others
  11. 1.4 Assumptions and Limitations
  12. 1.5 Study Goals and Objectives
2 Human Combination Vaccines Market Dynamics
  1. 2.1 Human Combination Vaccines Industry Trends
  2. 2.2 Human Combination Vaccines Industry Drivers
  3. 2.3 Human Combination Vaccines Industry Opportunities and Challenges
  4. 2.4 Human Combination Vaccines Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Human Combination Vaccines Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Human Combination Vaccines Revenue by Region
  3. 3.2.1 Global Human Combination Vaccines Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Human Combination Vaccines Revenue by Region (2021-2026)
  5. 3.2.3 Global Human Combination Vaccines Revenue by Region (2027-2032)
  6. 3.2.4 Global Human Combination Vaccines Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Human Combination Vaccines Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Human Combination Vaccines Sales by Region
  9. 3.4.1 Global Human Combination Vaccines Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Human Combination Vaccines Sales by Region (2021-2026)
  11. 3.4.3 Global Human Combination Vaccines Sales by Region (2027-2032)
  12. 3.4.4 Global Human Combination Vaccines Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Human Combination Vaccines Revenue by Manufacturers
  2. 4.1.1 Global Human Combination Vaccines Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Human Combination Vaccines Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Human Combination Vaccines Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Human Combination Vaccines Sales by Manufacturers
  6. 4.2.1 Global Human Combination Vaccines Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Human Combination Vaccines Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Human Combination Vaccines Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Human Combination Vaccines Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Human Combination Vaccines Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Human Combination Vaccines Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Human Combination Vaccines Manufacturers, Product Type & Application
  13. 4.7 Global Human Combination Vaccines Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Human Combination Vaccines Market CR5 and HHI
  16. 4.8.2 2025 Human Combination Vaccines Tier 1, Tier 2, and Tier 3
5 Human Combination Vaccines Market by Type
  1. 5.1 Global Human Combination Vaccines Revenue by Type
  2. 5.1.1 Global Human Combination Vaccines Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Human Combination Vaccines Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Human Combination Vaccines Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Human Combination Vaccines Sales by Type
  6. 5.2.1 Global Human Combination Vaccines Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Human Combination Vaccines Sales by Type (2021-2032) & (k units)
  8. 5.2.3 Global Human Combination Vaccines Sales Market Share by Type (2021-2032)
  9. 5.3 Global Human Combination Vaccines Price by Type
6 Human Combination Vaccines Market by Application
  1. 6.1 Global Human Combination Vaccines Revenue by Application
  2. 6.1.1 Global Human Combination Vaccines Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Human Combination Vaccines Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Human Combination Vaccines Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Human Combination Vaccines Sales by Application
  6. 6.2.1 Global Human Combination Vaccines Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Human Combination Vaccines Sales by Application (2021-2032) & (k units)
  8. 6.2.3 Global Human Combination Vaccines Sales Market Share by Application (2021-2032)
  9. 6.3 Global Human Combination Vaccines Price by Application
7 Company Profiles
  1. 7.1 Takeda Pharmaceuticals
  2. 7.1.1 Takeda Pharmaceuticals Company Information
  3. 7.1.2 Takeda Pharmaceuticals Business Overview
  4. 7.1.3 Takeda Pharmaceuticals Human Combination Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Takeda Pharmaceuticals Human Combination Vaccines Product Portfolio
  6. 7.1.5 Takeda Pharmaceuticals Recent Developments
  7. 7.2 Sanofi
  8. 7.2.1 Sanofi Company Information
  9. 7.2.2 Sanofi Business Overview
  10. 7.2.3 Sanofi Human Combination Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Sanofi Human Combination Vaccines Product Portfolio
  12. 7.2.5 Sanofi Recent Developments
  13. 7.3 Merck
  14. 7.3.1 Merck Company Information
  15. 7.3.2 Merck Business Overview
  16. 7.3.3 Merck Human Combination Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Merck Human Combination Vaccines Product Portfolio
  18. 7.3.5 Merck Recent Developments
  19. 7.4 GlaxoSmithKline
  20. 7.4.1 GlaxoSmithKline Company Information
  21. 7.4.2 GlaxoSmithKline Business Overview
  22. 7.4.3 GlaxoSmithKline Human Combination Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 GlaxoSmithKline Human Combination Vaccines Product Portfolio
  24. 7.4.5 GlaxoSmithKline Recent Developments
  25. 7.5 Serum Institute of India
  26. 7.5.1 Serum Institute of India Company Information
  27. 7.5.2 Serum Institute of India Business Overview
  28. 7.5.3 Serum Institute of India Human Combination Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Serum Institute of India Human Combination Vaccines Product Portfolio
  30. 7.5.5 Serum Institute of India Recent Developments
  31. 7.6 Daiichi Sankyo
  32. 7.6.1 Daiichi Sankyo Company Information
  33. 7.6.2 Daiichi Sankyo Business Overview
  34. 7.6.3 Daiichi Sankyo Human Combination Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Daiichi Sankyo Human Combination Vaccines Product Portfolio
  36. 7.6.5 Daiichi Sankyo Recent Developments
8 North America
  1. 8.1 North America Human Combination Vaccines Market Size by Type
  2. 8.1.1 North America Human Combination Vaccines Revenue by Type (2021-2032)
  3. 8.1.2 North America Human Combination Vaccines Sales by Type (2021-2032)
  4. 8.1.3 North America Human Combination Vaccines Price by Type (2021-2032)
  5. 8.2 North America Human Combination Vaccines Market Size by Application
  6. 8.2.1 North America Human Combination Vaccines Revenue by Application (2021-2032)
  7. 8.2.2 North America Human Combination Vaccines Sales by Application (2021-2032)
  8. 8.2.3 North America Human Combination Vaccines Price by Application (2021-2032)
  9. 8.3 North America Human Combination Vaccines Market Size by Country
  10. 8.3.1 North America Human Combination Vaccines Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Human Combination Vaccines Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Human Combination Vaccines Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Human Combination Vaccines Market Size by Type
  2. 9.1.1 Europe Human Combination Vaccines Revenue by Type (2021-2032)
  3. 9.1.2 Europe Human Combination Vaccines Sales by Type (2021-2032)
  4. 9.1.3 Europe Human Combination Vaccines Price by Type (2021-2032)
  5. 9.2 Europe Human Combination Vaccines Market Size by Application
  6. 9.2.1 Europe Human Combination Vaccines Revenue by Application (2021-2032)
  7. 9.2.2 Europe Human Combination Vaccines Sales by Application (2021-2032)
  8. 9.2.3 Europe Human Combination Vaccines Price by Application (2021-2032)
  9. 9.3 Europe Human Combination Vaccines Market Size by Country
  10. 9.3.1 Europe Human Combination Vaccines Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Human Combination Vaccines Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Human Combination Vaccines Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Human Combination Vaccines Market Size by Type
  2. 10.1.1 China Human Combination Vaccines Revenue by Type (2021-2032)
  3. 10.1.2 China Human Combination Vaccines Sales by Type (2021-2032)
  4. 10.1.3 China Human Combination Vaccines Price by Type (2021-2032)
  5. 10.2 China Human Combination Vaccines Market Size by Application
  6. 10.2.1 China Human Combination Vaccines Revenue by Application (2021-2032)
  7. 10.2.2 China Human Combination Vaccines Sales by Application (2021-2032)
  8. 10.2.3 China Human Combination Vaccines Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Human Combination Vaccines Market Size by Type
  2. 11.1.1 Asia Human Combination Vaccines Revenue by Type (2021-2032)
  3. 11.1.2 Asia Human Combination Vaccines Sales by Type (2021-2032)
  4. 11.1.3 Asia Human Combination Vaccines Price by Type (2021-2032)
  5. 11.2 Asia Human Combination Vaccines Market Size by Application
  6. 11.2.1 Asia Human Combination Vaccines Revenue by Application (2021-2032)
  7. 11.2.2 Asia Human Combination Vaccines Sales by Application (2021-2032)
  8. 11.2.3 Asia Human Combination Vaccines Price by Application (2021-2032)
  9. 11.3 Asia Human Combination Vaccines Market Size by Country
  10. 11.3.1 Asia Human Combination Vaccines Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Human Combination Vaccines Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Human Combination Vaccines Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Human Combination Vaccines Market Size by Type
  2. 12.1.1 SAMEA Human Combination Vaccines Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Human Combination Vaccines Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Human Combination Vaccines Price by Type (2021-2032)
  5. 12.2 SAMEA Human Combination Vaccines Market Size by Application
  6. 12.2.1 SAMEA Human Combination Vaccines Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Human Combination Vaccines Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Human Combination Vaccines Price by Application (2021-2032)
  9. 12.3 SAMEA Human Combination Vaccines Market Size by Country
  10. 12.3.1 SAMEA Human Combination Vaccines Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Human Combination Vaccines Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Human Combination Vaccines Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Human Combination Vaccines Value Chain Analysis
  2. 13.1.1 Human Combination Vaccines Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Human Combination Vaccines Production Mode & Process
  6. 13.2 Human Combination Vaccines Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Human Combination Vaccines Distributors
  9. 13.2.3 Human Combination Vaccines Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst